Disgraced pharmaceutical executive Martin Shkreli will not attend or testify at a civil trial next month that could result in his lifetime ban from the industry after a Manhattan federal judge denied his request to participate remotely.

U.S. District Judge Denise L. Cote said in a hearing Thursday that there were “many reasons” not to allow Shkreli to access the proceedings from a federal prison in Pennsylvania, where he is serving a seven-year prison sentence for defrauding investors in two of his hedge funds.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]